Friday, April 7, 2023

Two judges' dueling decisions have put access to a key abortion drug in jeopardy nationwide

A federal judge in Texas stayed the FDA's approval of the drug mifepristone, while a federal judge in Washington state has blocked any FDA change in access.

No comments:

Post a Comment